A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.

An over-the-counter nasal spray antihistamine reduced rates of COVID-19 infections and common colds in a midstage trial, ...

The over-the-counter antihistamine azelastine works against a range of respiratory infections, including the flu and RSV, ...

In addition to showing a marked reduction in coronavirus infections, the azelastine group also displayed fewer symptomatic ...

A new study out of Germany shows that azelastine — an antihistamine the Mayo Clinic said is used to treat seasonal and ...

Azelastine nasal spray was associated with a reduced risk for SARS-CoV-2 infection, according to the results of a phase 2 ...

This nasal spray has been available over the counter for decades now, under a variety of brand names, in over 70 countries.

New breakthrough research suggests that a common, over-the-counter nasal spray used to treat allergies may protect against ...

A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers ...

A single dose of neffy epinephrine nasal spray resulted in successful treatment of anaphylaxis symptoms during oral food ...

The performance of ARS Pharmaceuticals’ Neffy marginally outpaced historical reports of epinephrine injection effectiveness.

A clinical trial backed by numerous studies determined that a popular over-the-counter nasal spray used to treat allergies ...